Compare OPXS & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPXS | LNSR |
|---|---|---|
| Founded | 1987 | 2004 |
| Country | United States | United States |
| Employees | 72 | N/A |
| Industry | Electronic Components | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.8M | 71.7M |
| IPO Year | 2009 | 2005 |
| Metric | OPXS | LNSR |
|---|---|---|
| Price | $8.70 | $4.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.33 |
| AVG Volume (30 Days) | 12.0K | ★ 62.9K |
| Earning Date | 12-16-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.55 | N/A |
| EPS | 0.41 | ★ 0.56 |
| Revenue | $24,530,000.00 | ★ $58,435,000.00 |
| Revenue This Year | $3.54 | $4.22 |
| Revenue Next Year | $10.05 | $19.43 |
| P/E Ratio | $20.76 | ★ $8.20 |
| Revenue Growth | ★ 17.63 | 9.24 |
| 52 Week Low | $7.51 | $4.30 |
| 52 Week High | $16.19 | $12.94 |
| Indicator | OPXS | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 22.11 |
| Support Level | N/A | N/A |
| Resistance Level | $10.85 | $6.10 |
| Average True Range (ATR) | 0.39 | 0.31 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 50.11 | 18.56 |
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.